WO2001047509A3 - Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions - Google Patents
Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions Download PDFInfo
- Publication number
- WO2001047509A3 WO2001047509A3 PCT/GB2000/005006 GB0005006W WO0147509A3 WO 2001047509 A3 WO2001047509 A3 WO 2001047509A3 GB 0005006 W GB0005006 W GB 0005006W WO 0147509 A3 WO0147509 A3 WO 0147509A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- treatment
- diabetes mellitus
- cardiac conditions
- agent used
- insuline
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU23826/01A AU2382601A (en) | 1999-12-24 | 2000-12-22 | Novel method of treatment |
EP00987579A EP1261373A2 (en) | 1999-12-24 | 2000-12-22 | Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions |
JP2001548104A JP2003518493A (en) | 1999-12-24 | 2000-12-22 | New treatment methods |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9930688.8 | 1999-12-24 | ||
GBGB9930692.0A GB9930692D0 (en) | 1999-12-24 | 1999-12-24 | Novel method of treatment |
GB9930692.0 | 1999-12-24 | ||
GBGB9930689.6A GB9930689D0 (en) | 1999-12-24 | 1999-12-24 | Novel method of treatment |
GB9930689.6 | 1999-12-24 | ||
GBGB9930688.8A GB9930688D0 (en) | 1999-12-24 | 1999-12-24 | Novel method of treatment |
GB9930690.4 | 1999-12-24 | ||
GBGB9930690.4A GB9930690D0 (en) | 1999-12-24 | 1999-12-24 | Novel method of treatment |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/168,872 A-371-Of-International US20030060489A1 (en) | 1999-12-24 | 2000-12-22 | Novel method of treatment |
US10/803,300 Continuation US20040176373A1 (en) | 1999-12-24 | 2004-03-18 | Novel method of treatment |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001047509A2 WO2001047509A2 (en) | 2001-07-05 |
WO2001047509A3 true WO2001047509A3 (en) | 2002-09-12 |
Family
ID=27451929
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2000/005006 WO2001047509A2 (en) | 1999-12-24 | 2000-12-22 | Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1261373A2 (en) |
JP (1) | JP2003518493A (en) |
AU (1) | AU2382601A (en) |
WO (1) | WO2001047509A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE341343T1 (en) | 2000-12-26 | 2006-10-15 | Sankyo Co | MEDICAL COMPOSITIONS CONTAINING DIURETIC AND INSULIN RESISTANCE IMPROVEMENT AGENT |
CN100377744C (en) * | 2002-07-05 | 2008-04-02 | 安徽省生物医学研究所 | Compound medicine for predicting ACEI pressure reducing medicine effect |
ES2660170T3 (en) | 2007-01-25 | 2018-03-21 | NAIA Metabolic, Inc. | Insulin sensitizers and treatment methods |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0861666A2 (en) * | 1995-06-20 | 1998-09-02 | Takeda Chemical Industries, Ltd. | Pharmaceutical composition for use in treatment of diabetes |
EP0930076A1 (en) * | 1996-07-15 | 1999-07-21 | Sankyo Company Limited | Medicinal compositions |
WO2000027434A1 (en) * | 1998-11-11 | 2000-05-18 | Smithkline Beecham P.L.C. | Combinations comprising a beta-agonist and a further antidiabetic agent |
-
2000
- 2000-12-22 JP JP2001548104A patent/JP2003518493A/en not_active Withdrawn
- 2000-12-22 EP EP00987579A patent/EP1261373A2/en not_active Withdrawn
- 2000-12-22 AU AU23826/01A patent/AU2382601A/en not_active Abandoned
- 2000-12-22 WO PCT/GB2000/005006 patent/WO2001047509A2/en not_active Application Discontinuation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0861666A2 (en) * | 1995-06-20 | 1998-09-02 | Takeda Chemical Industries, Ltd. | Pharmaceutical composition for use in treatment of diabetes |
US5965584A (en) * | 1995-06-20 | 1999-10-12 | Takeda Chemical Industries, Ltd. | Pharmaceutical composition |
EP0930076A1 (en) * | 1996-07-15 | 1999-07-21 | Sankyo Company Limited | Medicinal compositions |
WO2000027434A1 (en) * | 1998-11-11 | 2000-05-18 | Smithkline Beecham P.L.C. | Combinations comprising a beta-agonist and a further antidiabetic agent |
Non-Patent Citations (3)
Title |
---|
DAGOGO-JACK S ET AL: "PATHOPHYSIOLOGY OF TYPE 2 DIABETES AND MODES OF ACTION OF THERAPEUTIC INTERVENTIONS", ARCHIVES OF INTERNAL MEDICINE, XX, XX, vol. 157, no. 16, 8 September 1997 (1997-09-08), pages 1802 - 1817, XP000872498 * |
HOSOKAWA, M. ET AL: "Troglitazone inhibits bicarbonate secretion in rat and human duodenum", J. PHARMACOL. EXP. THER. (1999), 290(3), 1080-1084, XP008002057 * |
SHIMOYAMA, MASAKI ET AL: "Hemodynamic basis for the acute cardiac effects of troglitazone in isolated perfused rat hearts.", DIABETES, (MARCH, 1999) VOL. 48, NO. 3, PP. 609-615., XP001035237 * |
Also Published As
Publication number | Publication date |
---|---|
WO2001047509A2 (en) | 2001-07-05 |
AU2382601A (en) | 2001-07-09 |
EP1261373A2 (en) | 2002-12-04 |
JP2003518493A (en) | 2003-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1787646A3 (en) | Novel method of treatment | |
SG127714A1 (en) | Method of treating metabolic disorders, especiallydiabetes, or a disease or condition associated wi th diabetes | |
CA2329004A1 (en) | Combination of insulin sensitizer with anorectic for treating or preventing diabetes | |
MY155219A (en) | Treatment of diabetes with thiazolidinedione, insulin secretagogue and biguanide | |
AU563642B2 (en) | Oral antidiabetic composition | |
IL198783A0 (en) | Erythropoietin ameliorates chemotherapy-induced toxicity in vivo | |
WO2004050115A3 (en) | Combination treatment using exendin-4 and thiazolidinediones | |
CA2208047A1 (en) | Increasing creatine and glycogen concentration in muscle | |
WO1996015784A3 (en) | 2,2-dichloroalkane carboxylic acids, process for preparing the same, medicament containing the same, and use thereof for treating insulin resistance | |
AP2000001735A0 (en) | Treatment of diabetes with thiazolidinedione insulin secretagogue and alpha glucocidase inhibitor. | |
WO2001047509A3 (en) | Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions | |
MY125855A (en) | Treatment of diabetes with a thiazolidinedione and sulphonylurea | |
AP9901720A0 (en) | Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitors. | |
WO2001070236A8 (en) | Preventing and/or treating diabetes mellitus | |
HUP0104388A2 (en) | Combinations comprising a betha-agonist and a further antidiabetic agent | |
UY25103A1 (en) | COMPOSITION FOR THE TREATMENT OF DIABETES MELLITUS | |
AU2003288793A1 (en) | Pharmaceutical compound containing silymarin and carbopol®, production method thereof and use of same as a regenerator of tissue and pancreatic cells with endogenous secretion damaged by diabetes mellitus | |
ECSP982542A (en) | NEW METHOD OF TREATMENT III | |
HUP0002569A2 (en) | Pharmaceutical compositions for treatment of diabetes containing thiazolidinedione and alpha-glucosidase inhibitors | |
HUP0002669A2 (en) | Treatment of diabetes with thiazolidinedione and sulphonylurea | |
NZ503862A (en) | Use of insulin sensitisers (especially thiazolidinediones) for the treatment of hyperglycaemia | |
ECSP982593A (en) | NEW METHOD OF TREATMENT VI | |
ECSP982541A (en) | NEW METHOD OF TREATMENT II | |
HUP0002668A2 (en) | Treatment of diabetes with thiazolidinedione and metformin | |
ECSP982591A (en) | NEW METHOD OF TREATMENT IV |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2001 548104 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000987579 Country of ref document: EP |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10168872 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2000987579 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000987579 Country of ref document: EP |